Home The Word Brain My Amedeo FAQ Privacy About


Hanzi Hunter

Learning 500 Chinese characters in 30 days is possible.

Abstract • About

  Nuclear Medicine

  Free Subscription


30.03.2026

1 AJNR Am J Neuroradiol
3 Ann Neurol
2 Ann Nucl Med
1 J Cereb Blood Flow Metab
3 J Nucl Cardiol
3 J Nucl Med
1 Neurol Genet


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJNR Am J Neuroradiol

  1. ELMOUJARKACH E, Sharbatdaran A, Pontolillo L, Jean J, et al
    Dynamic Brain [F18]-Fluoroestradiol (FES) PET Protocol Optimization for Improved Detection of Breast Cancer Brain Metastases.
    AJNR Am J Neuroradiol. 2026 Mar 26:ajnr.A9316. doi: 10.3174/ajnr.A9316.
    PubMed         Abstract available


    Ann Neurol

  2. PEJHAN S, Budhram A, Hammond R, Zhang Q, et al
    Cerebral Amyloidoma: An Update Following "Fixation Duress" on PET.
    Ann Neurol. 2026 Mar 24. doi: 10.1002/ana.78209.
    PubMed        

  3. FRASER JA, Romsa JG, Budhram A, Li CMF, et al
    Reply to "Cerebral Amyloidoma: An Update Following 'Fixation Duress' on PET".
    Ann Neurol. 2026 Mar 23. doi: 10.1002/ana.78210.
    PubMed        

  4. FAN Z, Searle G, Rizzo G, Albani J, et al
    Toward Harmonizing Quantification of Dopamine Neuron Imaging Biomarkers in Parkinson's Disease: The Centamine Scale.
    Ann Neurol. 2026 Jan 20. doi: 10.1002/ana.78116.
    PubMed         Abstract available


    Ann Nucl Med

  5. VALSAMAKI PN, Tsakaldimis G
    Non-metastatic castration-resistant prostate cancer in the epoch of PSMA-ligand PET/CT: twilight?
    Ann Nucl Med. 2026 Mar 26. doi: 10.1007/s12149-026-02195.
    PubMed         Abstract available

  6. TSOUGOS I, Valotassiou V, Tsivaka D, Satra M, et al
    SPECT and PET imaging of Alzheimer's disease revisited: from biomarkers to artificial intelligence-based prediction.
    Ann Nucl Med. 2026 Mar 26. doi: 10.1007/s12149-026-02194.
    PubMed        


    J Cereb Blood Flow Metab

  7. KUDOMI N, Maeda Y, Kobata T, Morimoto M, et al
    A reference-based approach using whole-brain segmentation for image-derived PET input functions in CBF, OEF, and CMRO(2) quantification.
    J Cereb Blood Flow Metab. 2026 Mar 21:271678X261431225.
    PubMed         Abstract available


    J Nucl Cardiol

  8. MURPHY NP, Cremer PC
    Quantifying what matters: Clarifying the value of longitudinal flow gradients in [82Rb]rubidium-positron emission tomography myocardial perfusion imaging.
    J Nucl Cardiol. 2026;57:102648.
    PubMed        

  9. KWIECINSKI J
    Harnessing the full potential of positron emission tomography myocardial perfusion imaging with artificial intelligence.
    J Nucl Cardiol. 2026;57:102593.
    PubMed        

  10. NISHI T, Ota S, Shiono Y, Takano Y, et al
    Value of single-photon emission computed tomography for diagnosing transthyretin amyloid cardiomyopathy: Correlation with endomyocardial biopsy.
    J Nucl Cardiol. 2026;57:102595.
    PubMed         Abstract available


    J Nucl Med

  11. KIMURA K, Livhits MJ, Laklouk IA, Gupta PK, et al
    [(68)Ga]Ga-FAPI-46 PET/CT in Adrenocortical Neoplasm, Oncocytic Type.
    J Nucl Med. 2026 Mar 26:jnumed.125.270788. doi: 10.2967/jnumed.125.270788.
    PubMed        

  12. WIDJAJA L, Hornfeck J, Siegmund SC, Gildehaus FJ, et al
    Prognostic Value of Early Follow-Up PSMA PET/CT After 2 Cycles of [(177)Lu]Lu-PSMA RPT in Patients with mCRPC: Comparison with PSA Dynamics.
    J Nucl Med. 2026 Mar 26:jnumed.125.271859. doi: 10.2967/jnumed.125.271859.
    PubMed         Abstract available

  13. GEENS W, Buyck F, Raes L, Schwarze JK, et al
    Prognostic Value of O-(2-(18)F-Fluoroethyl)-l-Tyrosine PET for Patients with Recurrent Glioblastoma.
    J Nucl Med. 2026 Mar 26:jnumed.125.270727. doi: 10.2967/jnumed.125.270727.
    PubMed         Abstract available


    Neurol Genet

  14. TANASE MG, Djilani L, Lamontagne R, Derbel R, et al
    Utility of 18F-FDG PET/CT in the Surveillance of Patients With Neurofibromatosis Type 1.
    Neurol Genet. 2026;12:e200361.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum